News

Awards, honors, prizes and achievements for the week of Aug. 16 - Aug. 23.

Patients with an aggressive lymphoma that often relapses and kills within two years experienced a remission of their cancer and stayed disease-free as long as 28 months after taking a commercially-available drug that made chemotherapy more effective.

A roundup of new research from Weill Cornell's physicians and scientists. In this installment, a new mouse model from Dr. Lorraine Gudas and Dr. David Nanus inspires new insights on human clear cell renal cancer.

Awards, honors, prizes and achievements for the week of Aug. 9 - Aug. 16.

Initiatives to improve health care increasingly link physician payment to quality of care. But studies so far have shown mixed findings about whether or not these "pay-for-performance" programs actually improve care.

Patients like it and so do health organizations, but electronic communications in clinical care will likely not be widely adopted by primary care physicians unless physician workloads are reduced or they are paid for the time they spend phoning and emailing patients, both during and after office hours.

A roundup of new research from Weill Cornell's physicians and scientists. In this installment, a study from Dr. Michel Kahaleh on the safety and efficacy of a modified diagnostic and therapeutic technique for pregnant women with gall stones, strictures or other conditions of the biliary or pancreatic ductal systems, and a study from Dr. Madelon Finkel about the use of anthocyanin-rich purple corn extract in lowering high blood pressure.

Awards, honors, prizes and achievements for the week of July 26 - Aug. 2.

The enormous promise of regenerative medicine is matched by equally enormous challenges. But a new finding by a team of researchers led by Weill Cornell Medical College has the potential to improve both the safety and performance of reprogrammed cells.

Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses. The study, led by researchers at Weill Cornell Medical College, sets the stage for testing the drug in clinical trials of diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma, itself the seventh most frequently diagnosed cancer in the U.S.

Dr. Laurie H. Glimcher speaks with Dr. Christopher Mason, an assistant professor of physiology and biophysics and assistant professor of computational genomics. Dr. Mason recently celebrated a victory, testifying before the U.S. Supreme Court on behalf of genetic liberty.

Awards, honors, prizes and achievements for the week of July 19 - July 26.

While significant advances have been made in HIV treatment, experts say one of the obstacles still facing many HIV-positive patients is adherence to a daily regimen of medication. That may soon change. A new smart pill bottle slated for clinical trial at Weill Cornell Medical College this fall has the promise to significantly dismantle -- perhaps even tear down -- that health care barrier.

This month, Qatari high school students embarked on a journey of exploration as the winners of Weill Cornell Medical College in Qatar's annual Healing Hands essay contest. Their prize: a two-week, all-expenses paid trip to Weill Cornell Medical College in New York to learn the ins and outs of the medical profession.

On July 1, when New York Downtown Hospital became NewYork-Presbyterian/Lower Manhattan Hospital as a result of a merger, New Yorkers living and working in lower Manhattan gained expanded access to Weill Cornell Medical College's faculty of distinguished physicians.

Awards, honors, prizes and achievements for the week of July 12 - July 19

Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings today from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease at the Alzheimer's Association International Conference (AAIC) in Boston, Mass. While the primary study outcomes were negative, observations from the subgroup analyses include whether there may be a dose-dependent reduction of beta amyloid in the blood and brain of IVIG-treated Alzheimer's patients who have the ApoE4 genotype.

Smokers who've received a clean bill of health from their doctor may believe cigarettes haven't harmed their lungs. However, researchers at Weill Cornell Medical College have found that even smokers who seem healthy have damaged airway cells, with characteristics similar to cells found in aggressive lung cancer.

Patients need to understand their medical conditions in order for them to take an active role in their health care, experts say. Asking their doctors questions is a key -- but frequently challenging -- part of this process, according to a recent Journal of the American Medical Association article.

Awards, honors, prizes and achievements for the week of July 5 - July 12.